Skip to content

Altimmune ALT Common Stock

Common Stock at other companies

Eli Lilly logo
Eli LillyLLY
$590M-0.4%
Madrigal Pharmaceuticals, Inc. logo
Madrigal Pharmaceuticals, Inc.MDGL
200M0.0%
Viking Therapeutics logo
Viking TherapeuticsVKTX
$1K0.0%
Wave Life Sciences logo
Wave Life SciencesWVE
$1.63B+37.9%
Delcath Systems logo
Delcath SystemsDCTH
80M0.0%
MeiraGTx Holdings plc logo
MeiraGTx Holdings plcMGTX
$3K0.0%

Other financials

Income statement

See full
Revenue$26.0K+420%
Operating income-$24.2M-11.1%
Net income-$22.6M-15.3%
EPS (diluted)-$0.18+30.8%

Balance sheet

See full
Cash & equivalents$97.6M+98.7%
Total debt$34.8M+14,092%
Total equity$284.0M+99.8%
Total assets$335.6M+113%

Cash flow

See full
Operating cash flow-$20.9M-24.4%
CapEx$21.0K
Free cash flow-$21.0M

Valuation

See full
Market cap$558.14M-2.1%
Enterprise value$495.27M-5.0%
P/S13,613.2×-24,380×

Profitability

See full
Operating margin-230,461%-82,087pp
Net margin-214,861%-76,057pp
FCF margin-17,806.8%-110,030pp

Returns & leverage

See full
Return on equity-42.7%-8.7pp
Debt / equity0.1×+0.1×
Current ratio29.6×+13.7×

Where this comes from

Reported directly by Altimmune in its filing.

Tagged under the XBRL concept us-gaap:CommonStockValue.

The official record: Altimmune’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Altimmune's common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Altimmune's common stock?
Altimmune (ALT) reported common stock of $13K in Q1 2026.
How has Altimmune's common stock changed year-over-year?
Altimmune's common stock increased by 62.5% year-over-year, from $8K to $13K.
What is the long-term trend for Altimmune's common stock?
Over 5 years (2020 to 2025), Altimmune's common stock has grown at a 24.4% compound annual growth rate (CAGR), from $3.7K to $11K.
What does common stock mean?
The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).